节点文献
新型免疫调节药来那度胺的药理及临床研究进展
A new immunomodulatory drug lenalidomide: pharmacological activity and clinical research
【摘要】 来那度胺是一种新型免疫调节药,主要用于治疗多发性骨髓瘤和骨髓增生异常综合征。本品为沙利度胺的衍生物,通过相对小的结构修饰,提高药效,减少不良反应。现对其作用机制、药动学、临床应用、不良反应、药物相互作用等做一综述。
【Abstract】 Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome. By the minor structural modifications, this agent shows more potent and safe profiles compared with the parent compound. This paper summarizes the mechanism, pharmacokinetics, clinical application, adverse reactions and drug interactions of lenalidomide.
【关键词】 免疫调节药;
来那度胺;
多发性骨髓瘤;
骨髓增生异常综合征;
【Key words】 immunomodulatorv drug; lenalidomide; multiple myeloma; myelodysplastic syndrome;
【Key words】 immunomodulatorv drug; lenalidomide; multiple myeloma; myelodysplastic syndrome;
- 【文献出处】 中国新药杂志 ,Chinese Journal of New Drugs , 编辑部邮箱 ,2006年21期
- 【分类号】R96
- 【被引频次】21
- 【下载频次】1224